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Supplementary Fig. 1 Identification and confirmation of FH as ligand for FHR. a The 145 kDa 
protein pulled down by FHR was analysed by mass spectrometry and identified as bovine FH (protein 
score = 3466; significant peptides = 168, threshold = 0.05). Peptides that mapped onto the sequence 
of bovine FH are shown in black, peptides missing in red, and signal peptide in grey. Sequence 
coverage was 81.3 %. b SDS-PAGE analysis of recombinant FHR used for SPR analysis. Samples 
are shown before and after biotinylation. c Western blot of samples from b probed with streptavidin 
peroxidase. d SDS-PAGE analysis of FH purified from bovine serum and recombinant bovine FH. e 
SPR binding data (black) for C-terminally biotinylated FHR (450 RU) bound to a streptavidin chip with 
two-fold dilutions of FH from bovine serum overlaid with fits (red) to determine the KD. A two-state 
binding model was used for data from 1 μM to 31.25 nM producing a KD of 153 nM. f SPR binding 
data (black) for C-terminally biotinylated FHR (450 RU) bound to a streptavidin chip with two-fold 
dilutions of recombinant bovine FH (1 μM highest concentration) overlaid with fits (red) to determine 
the KD. A two-state binding model was used for data from 1 μM to 31.25 nM producing a KD of 114 
nM. g The T. brucei FHR sequence was aligned with the closest T. congolense (TcIL3000.0.47410) 
and T. suis homologues. Selected conserved residues near the N-terminus were mutated to alanine 
(blue) in different combinations. Signal peptides are shown in grey. h Sequence of first the 27 residues 
of recombinant FHR and the changes made to produce mutants 1, 2 and 3. i SDS-PAGE analysis of 
pulldowns from bovine serum were performed with GST fusion proteins of wild type FHR and mutants 
1, 2 and 3 immobilised on beads. Two replicates for each are shown along with a PBS control. Source 
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Supplementary Fig. 2 Determination of the FH-FHR binding interface. a Circular dichroism 
spectra at 20 °C for WT FHR (red) and mutant 2 (black), showing similar profiles with minima 208 and 
222 nm, indicative of a high alpha helical content. b Thermal melting analysis for WT FHR (red) and 
mutant 2 (black) by circular dichroism at 220 nm, showing similar profiles and protein folding up to at 
least 50 °C. Spectra (190 to 250 nm) were recorded starting at 20 °C, followed by 0.5 °C incremental 
increases to 96 °C. c Same as in a, but for mutant 3. d Same as in b, but for mutant 3. e SDS-PAGE 
analysis as in Fig. 1c except with H12disuccimidyl suberate (DSS). f Western blot of samples in e, 
and performed as in Fig. 1d except with H12 DSS, probed with streptavidin peroxidase. g FHR and 
FH crosslinked peptides as identified by mass spectrometry. No crosslinked peptides were found in 
the mutant 3 and FH sample. This data contains all significant crosslinked peptides (e-value < 1x10-
5) found using both D12 and H12 DSS reactions and all crosslinks were shared between the two, 
except FHR residue 96 to FH residue 444 which was unique to H12 DSS. ‘Sequencing events’ 
represents the number of times a crosslinked peptide with a significant score was sequenced. FHR 
residue 24 is the N-terminal glycine left after TEV protease cleavage and is not part of the native 
sequence but is numbered accordingly. Red, FHR sequence; Black, FH sequence; Bold letter, 
crosslinked residue; Black line, crosslink; Res #, residue number. Source data are provided as a 































































24 283 5 GNDNLEAELEQTK
|
34
24 1218 20 GNDNLEAELEQTK
|
2
96 444 8 RAEAGAVGGTSEQQQAAKR
|
6
96 448 8 RAEAGAVGGTSEQQQAAKR
|
4
120 1195 20 AEAAAMEVKR
|
3





















































thermal melting (222 nm)











































































CD spectra for FHR and mutant 3 thermal melting (222 nm)
Supplementary Fig. 3 Validation of the interaction between FHR and FH domain 5. a SDS-PAGE 
of (left) recombinant bovine FH domains 4-5-6, 7-8-9, and 18-19-20 purified from culture supernatant 
by nickel chromatography, later followed by gel filtration before SPR, and (right) recombinant FHR 
and bovine FH domain 5, mixed in a 1:1.05 molar ratio, co-purified by gel filtration for crystallography. 
b SPR binding data (black) for C-terminally biotinylated FHR (400 RU) bound to a streptavidin chip 
with two-fold dilutions of FH domain 5 overlaid with fits (red) to determine the KD. A 1:1 binding model 
was used for data from 5 μM to 312.5 nM producing a KD of 562 nM. c Same as b, except with FH 
domains 4-5-6 and data was analysed from 1.5 μM to 93.75 nM, producing a KD of 167 nM. d Same 
as b, except with mutant 2 FHR (400 RU) and two-fold dilutions of recombinant bovine FH with 1 μM 
as the highest concentration. e Same as d, except with FH domain 5 and 5 μM as the highest 
concentration. f Two adjacent asymmetric units, each containing two copies of FHR and two copies 
of domain 5. Complex 1, FHR (blue) and domain 5 (dark pink) and complex 2, FHR (purple) and 
domain 5 (light pink). Boxed region is zoomed into and rotated in g. g Rotation of two adjacent 
asymmetric units showing close proximity of domain 5 from one unit to FHR of the adjacent unit. 
Residues E31 and Q34 were mutated to alanines (mutant 2) to confirm the identification of the true 
binding interface. h Representative stereo view of electron density map in grey mesh (2Fo−Fc, 
contour = 1σ) for a cross-section of FHR alpha helices. i Location (N150) of the single predicted N-
glycosylation site (orange) for FHR. j Alignment of solution structures for domains 1-5 of human FH 
(2QFG) holding domain 5 (dark blue) in place. There is a wide range of conformations for domains 1-
4 (grey), demonstrating the flexibility at the domain 4-5 boundary. Source data are provided as a 






































domains 4-5-6 binding to








domain 5 binding to



























































Supplementary Fig. 4 FHR interacts with a range of mammalian FH. a-b SDS-PAGE analysis of 
pulldowns from a range of mammalian sera were performed with a GST-FHR immobilised on beads 
or b along with a GST control. The same GST-FHR samples are run in a and b and are representative 
of two independent replicates. c SDS-PAGE analysis of recombinant mouse and human FH domains 
4-5-6. d SPR binding data for C-terminally biotinylated WT FHR (900 RU) and mutant 2 FHR (900 
RU) bound to a streptavidin chip and two-fold dilutions of bovine, mouse, and human FH domains 4-
5-6 (10 μM highest concentration). e Steady state analysis (Req) versus increasing concentrations of 
mouse and human FH domains 4-5-6 in d to determine the KD (12 μM for mouse and 8.7 μM for 
human). f SPR binding data for C-terminally biotinylated WT FHR (500 RU) bound to a streptavidin 
chip and 1:10, 1:20, 1:40, 1:80, and 1:160 dilutions of bovine serum and Cfh+/+ and Cfh-/- mouse 
plasma. Source data are provided as a Source Data file.  
bovine domains 4-5-6 to FHR
bovine domains 4-5-6 to mutant 2
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Supplementary Fig. 5 Generation and investigation of FHR-/- cell lines. a Schematic of the FHR 
locus before and after gene replacement with resistance cassettes showing the NdeI and NcoI 
restriction sites. b Southern blot analysis of genomic DNA from parental and FHR-/- cell lines used to 
confirm the successful production of six FHR-/- clones. c Western blot analysis of FHR expression in 
four biological replicates using whole cell lysates from cultured PCFs and loading 1 x 106 cell 
equivalents per lane. d Estimation of FHR copy number in PCFs using semi-quantitative western 
blotting. The anti-FHR signal from 1 x 106 cell equivalents was roughly equal to 83 ng of recombinant 
FHR. The limit of detection in this experiment for FHR was 0.081 ng. c and d were probed with FHR 
antiserum (αFHR) and anti-PFR (αPFR) as loading control. e The transmission of T. brucei FHR+/+ 
and FHR-/- cell lines to tsetse flies in the absence of complement was not significantly different. Tsetse 
flies were fed FHR+/+ and three independent FHR-/- clones derived as PCFs from culture in the 
absence of active complement and transmission of the infection was evaluated by the dissection of ³ 
20 midguts per cell line on day 6 post infection. The number of infected midguts over the total 
dissected midguts is plotted, whereby 18/20 were infected for FHR+/+, 20/22 for FHR-/- clone 1, 16/24 
for FHR-/- clone 2, and 22/30 for FHR-/- clone 3. There was no significant difference between the 
FHR+/+ and each of the FHR-/- clones (P > 0.08 for each cell line by chi-squared test). f Growth of 
FHR+/+ and FHR-/- PCF cell lines in culture. g Growth of FHR+/+ and FHR-/- BSF cell lines in culture. 
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Supplementary Fig. 6 FHR is upregulated and present on the cell surface of induced stumpy 
BSFs. Immunofluorescence detection of the FHR in FHR+/+ induced stumpy BSFs showing a larger 
selection of cells than Fig. 5d and representative of a population in which 100% of cells were positive 
(n=100). FHR expression was not detected in 98% of FHR+/+ slender BSF (n=100). No fluorescence 
was detected for FHR-/- cells. Cells shown in Fig. 5d are marked by an asterisk (*). Scale bar, 10 μm. 
DNA, Hoechst staining of the nuclear and kinetoplastid DNA. Cells positioned with the posterior 
towards the top right corner.  
FHR-/- BSFs
DIC FHR DNA Merge
FHR+/+ BSFs





Supplementary Fig. 7 The FHR is upregulated and present on the cell surface of PCFs in the 
tsetse fly. Immunofluorescence detection of the FHR in FHR+/+ PCFs isolated from the tsetse fly 
midgut showing a larger selection of cells than Fig. 5d and representative of a population in which 
100 % of cells were positive (n = 100 cells). Dissections were performed on days 3 and 10 post 
infection. No fluorescence was detected for FHR-/- cells. Cells shown in Fig. 5d are marked by an 
asterisk (*). Scale bar, 10 μm. DNA, Hoechst staining of the nuclear and kinetoplastid DNA. Cells 
positioned with the posterior towards the top right corner.  
FHR-/- PCFs









Supplementary Fig. 8 The FHR is upregulated and present on the cell surface of mesocyclic 
forms, but not detected in epimastigote forms in the tsetse fly. Immunofluorescence detection of 
the FHR in FHR+/+ mesocyclic forms and epimastigote forms isolated from the tsetse fly 
proventriculus showing a larger selection of cells than Fig. 5d. Dissections were performed on day 10 
post infection. Mesocyclic and epimastigote forms were identified based on the relative positioning of 
the kinetoplast and nucleus. No fluorescence was detected for FHR-/- cells. Cells shown in Fig. 5d 
are marked by an asterisk (*). Scale bar, 10 μm. DNA, Hoechst staining of the nuclear and 
kinetoplastid DNA. Cells positioned with the posterior towards the top right corner.  
FHR-/- mesocyclic to epimastigote forms
DIC FHR DNA Merge
FHR+/+ mesocyclic to epimastigote forms











Supplementary Fig. 9 Parasitaemia of T. brucei FHR+/+ and two FHR-/- cell lines in mice and 
predicted stumpy BSF concentration and lifespan. a Mouse blood parasitaemia of parental 
FHR+/+ and two independent FHR-/- clones from 3 to 14 days post infection. Five immunosuppressed 
BALB/c mice were infected with each cell line. The parasitaemia for each individual mouse is shown 
as well as an overlay. b Mouse blood parasitaemia of parental FHR+/+ and two independent FHR-/- 
clones from 2 to 24 days post infection. Five immunocompetent BALB/c mice were infected with each 
cell line. The parasitaemia for each individual mouse is shown as well as an overlay. c Predicted 
mean stumpy BSF concentration for each individual immunocompetent mouse in b from mathematical 
modelling (Supplementary Fig. 10 and Supplementary Data 1). Horizontal line represents the overall 
mean value for each cell line. d Predicted lifespan of stumpy BSFs in each individual 
immunocompetent mouse in b from mathematical modelling (Supplementary Fig. 10 and 
Supplementary Data 1). Horizontal line represents the mean value for each cell line. Source data are 
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Supplementary Fig. 10 Model dynamics of parasitaemia in immunocompetent mice. Model 
dynamics are shown for: a FHR+/+, b FHR-/- clone 1, and c FHR-/- clone 2. For all, blue lines show 
median fits and blue regions show 95% confidence interval. Row 1 shows the model fit to the 
parasitaemia of individual mice (Supplementary Fig. 9b) projected from days 0 to 24 post infection 
and blue circles show data. Row 2 shows the predicted stumpy induction factor concentration1. Rows 
3 and 4 show the predicted proportion of slender and stumpy BSFs. Source data are provided as a 






















Tb927.5.4010 Tb927.5.4010  ESP4 
Tb927.5.4020 Tb927.5.4020 3HB Fam19 & 50 
Tb927.6.440 TbbHpHbR 3HB   





Tb927.8.930 Tb927.8.930 3HB-3HB Fam50 
Tb927.8.950 Tb927.8.950 
Tb927.8.7310 Tb927.8.7310   
Tb927.8.7330 Tb927.8.7330 





Tb927.9.13200 Tb927.9.13200   
Tb927.9.15650 Tb927.9.15650 3HB  
Tb927.10.4380 Tb927.10.4380   
Tb927.10.4390 Tb927.10.4390 
Tb927.10.5700 Tb927.10.5700  Fam7 & ESP3 
Tb927.10.5710 Tb927.10.5710 
Tb927.11.4070 Tb927.11.4070   
Tb927.11.4760 Tb927.11.4760 3HB Fam50 
 
aGene ID’s have been taken from the TriTryp database2. Some genes are single copy genes, while others are 
members of small gene families. 
bProtein names are denoted as their gene ID. Tb927.6.440 encodes the T. b. brucei haptoglobin haemoglobin 
receptor (TbbHpHbR)3.  
cThree helical bundle (3HB) indicates predicted structural homology to known trypanosome 3HB surface 
proteins. The structure for the TbbHpHbR has been determined (PDB 4X0J) and is denoted as 3HB4. Mature 
polypeptides were used to search for structural homologues5,6.  
dData from previous cell surface proteome studies is shown: cell surface phylome family (Fam#)7 or enriched 















































Space group C 1 2 1 
Cell dimensions   
    a, b, c (Å) 160.50, 66.06, 71.02  
     a, b, g (°) 90.00, 94.44, 90.00 
Resolution (Å) 27.77 (2.70)  
Rmerge 0.157 (0.609) 
Rpim 0.112 (0.415) 
I/ s(I) 7.4 (2.9) 
CC1/2 0.978 (0.740) 
Completeness (%) 98.8 (98.5) 




Resolution (Å) 2.70 
Number of unique reflections 20315 (1049) 
Rwork / Rfree  0.188 / 0.252 
Number of residues  
     Protein 544 
     Water 188 
R.m.s. deviations   
     Bond lengths (Å) 0.010 
     Bond angles (°) 1.14 
Ramachandran plot  
     Favoured (%) 99.3 
     Allowed (%) 0.7 
     Disallowed (%) 0 
 






































N27 side chain OD1 & ND2 yes S282 side chain OG hydrogen bond 
side chain OD1 & ND2 yes K283 main chain N hydrogen bond 
side chain OD1 yes K283 main chain O hydrogen bond 
E31 side chain OE1 no R278 side chain NH1/2 salt bridge 
Q34 side chain OE1 no E280 main chain N hydrogen bond 
S131 side chain OG no K296 sidechain NZ hydrogen bond 
E132 main chain O yes K296 main chain N hydrogen bond 
V136 side chain no V276 side chain hydrophobic 
L140 side chain no V276 side chain hydrophobic 
R142 side chain NH1 yes E293 side chain OE2 hydrogen bond 
H147 side chain NE1/2 no D306 side chain OD1/2 salt bridge 
Y184 side chain OH yes R278 side chain NH2 hydrogen bond 
M185 main chain N no E280 side chain OE1/2 hydrogen bond 
Q186 side chain NE2 no E280 side chain OE2 hydrogen bond 
side chain OE1 no Y277 main chain N hydrogen bond 
F188 main chain N yes G275 main chain O hydrogen bond 
side chain no V276 side chain hydrophobic 
E191 side chain OE1/2 no K295 side chain NZ salt bridge 
 
Alignment of FH domain 5 from several mammals 
             265    275       285       295       305       315 
bovine      EITCDPPRIPNGVYRPELSKYRGQDKITYECKKGFFPEIRGTDATCTRDGWVPVPRCAWK  
sheep       EIICDPPRIPNGVYRPELSKYRGQDKITYECKKGFIPEIRGTEATCTRDGWAPAPRCAWK   
goat        EIICDPPRIPNGVYRPELSKYRGQDKITYKCKKGFIPEIRGTEATCTRDGWAPAPRCAWK   
pig         EITCDPPHIPNGFYTPESNRYRTGDRITYHCKEGFYPEIQGNVARCTGNHWSPAPRCTLK   
horse       EVTCDPPYIPNGVYSPRRTKHRTEDEIRYECTNGFYPATRGNTARCTSSGWVPSPRCSLK  
rabbit      EVTCNAPYIPNGSYLPKRIQHRTGDEIKYECKTGFYPATRGNTARCTGSGWVPGPRCSLK   
rat         EMTCLTPYIPNGIYTPHRIKHRIDDEIRYECKNGFYPATRSPVSKCTITGWIPAPRCSLK  
mouse       EKRCSPPYILNGIYTPHRIIHRSDDEIRYECNYGFYPVTGSTVSKCTPTGWIPVPRCTLK   
human       EKSCDNPYIPNGDYSPLRIKHRTGDEITYQCRNGFYPATRGNTAKCTSTGWIPAPRCTLK  
            *  *  * * ** * *    :*  *.* *.*  ** *   .  : **   * * ***: *
 
Supplementary Table 4 Conservation of domain 5 binding residues in other mammals.  
 
 
Bovine FH domain 5 interactions with FHRa 
 
 
























Human    
S282 side chain OG hydrogen bond ✓ ✓ * *     
K283 main chain N hydrogen bond ✓ ✓ * ✓ * ✓ * ✓ 
K283 main chain O hydrogen bond ✓ ✓ * ✓ * ✓ * ✓ 
R278 side chain NH1/2 salt bridge ✓ ✓       
E280 main chain N hydrogen bond ✓ ✓ ✓ * * * * * 
K296 sidechain NZ hydrogen bond ✓ ✓ * * * *  * 
K296 main chain N hydrogen bond ✓ ✓ * * * * * * 
V276 side chain hydrophobic ✓ ✓ * ✓  * *  
V276 side chain hydrophobic ✓ ✓ * ✓  * *  
E293 side chain OE2 hydrogen bond ✓   ✓ ✓ ✓ ✓ * 
D306 side chain OD1/2 salt bridge * *       
R278 side chain NH2 hydrogen bond ✓ ✓ * *  * * * 
E280 side chain OE1/2 hydrogen bond ✓ ✓ ✓      
E280 side chain OE2 hydrogen bond ✓ ✓ ✓      
Y277 main chain N hydrogen bond ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
G275 main chain O hydrogen bond ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
V276 side chain hydrophobic ✓ ✓ * ✓  * *  
K295 side chain NZ salt bridge ✓ ✓ ✓  ✓ ✓  * 
✓ 17 16 6 8 4 6 3 4 
* 1 1 9 5 5 7 8 6 
total 18 17 15 13 9 13 11 10 
 
aFocusing only on ligand residues from Supplementary Table 3, there are a total of 18 contacts/interactions that bovine FH 
domain 5 makes with FHR which is mediated by 11 domain 5 residues.   
bSome bovine residue interactions were absolutely conserved in other mammals (✓), while some residues were not 
conserved but were replaced by a residue that could perform the same interaction (*). Residues were deemed (*) if the 
other mammal contained a residue with a side chain that could perform the same interaction or if the interaction involved a 
main chain nitrogen or oxygen which is independent of side chain. Blank cells represent non-conserved interactions.  
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